STOCK TITAN

Heska Third Quarter 2022 Financial Results and Earnings Call Scheduled for November 8, 2022

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

LOVELAND, Colo., Oct. 18, 2022  /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty solutions, will report its third quarter 2022 financial performance in a press release before the market opens on Tuesday, November 8, 2022. The Company will also host an earnings call at 9 a.m. MT / 11 a.m. ET to discuss the results.

To access the conference call:

From within the United States, please dial 1-800-239-9838
From outside of the United States, please dial 1-323-794-2551
Reference Conference ID: 7035658

The earnings call will be webcast live from the Company's investor relations website at: Heska Corporation Third Quarter 2022 Earnings Call Webcast.

A telephonic replay will be available at 2 p.m. ET on November 8th through 11:59 p.m. ET on November 22, 2022 and the webcast will be archived on the Company's website for 90 days.

To access the replay by telephone:

From within the United States, please dial 1-844-512-2921
From outside the United States, please dial 1-412-317-6671
Reference Replay Pin Number: 7035658

About Heska
Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostics, informatics, and specialty healthcare solutions through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production for third-parties, primarily for herd animal health. For more information, please visit www.heska.com.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/heska-third-quarter-2022-financial-results-and-earnings-call-scheduled-for-november-8-2022-301651800.html

SOURCE Heska Corporation

HSKA

NASDAQ:HSKA

HSKA Rankings

HSKA Latest News

HSKA Stock Data

1.31B
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
US
Loveland

About HSKA

heska corporation (nasdaq: hska) is dedicated to perfecting and supporting the core technology and services that truly impact the quality of pet care and help to ensure positive outcomes for veterinarians and their patients. heska was created by veterinary professionals for veterinary professionals. our pledge to customers is to stand behind sound science, following best medical practices. heska’s line of diagnostic and imaging advancements include state-of-the-art chemistry, hematology, and blood gas & electrolyte systems, as well as single-step heartworm, early renal healthscreens, allergy testing and allergy treatment. heska also leads the way with the latest hd digital radiography, digital ultrasound, and pacs imaging technologies from cuattro. we help veterinary practices discover the right product solutions for their clients and patients; improving patient care, productivity and profitability. heska’s corporate headquarters are in loveland, colorado. we provide our products a